Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
PainChek Ltd ( (AU:PCK) ) has issued an announcement.
PainChek Ltd has announced the quotation of 1,146,013 fully paid ordinary securities on the ASX, following the exercise of options or conversion of other convertible securities. This move is expected to enhance the company’s financial flexibility and potentially strengthen its market position by increasing its capital base, which could have positive implications for its stakeholders.
More about PainChek Ltd
PainChek Ltd operates in the healthcare technology industry, focusing on developing innovative pain assessment solutions. The company’s primary product is a mobile application that uses facial recognition technology to assess pain levels in individuals who are unable to communicate effectively, with a market focus on improving patient care in clinical settings.
Average Trading Volume: 1,993,628
Technical Sentiment Signal: Buy
Current Market Cap: A$111.4M
For detailed information about PCK stock, go to TipRanks’ Stock Analysis page.